Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Braintree and partner Ipsen Group (Euronext:IPN; Pink:IPSEY, Boulogne-Billancourt, France) said Eziclen/Izinova was approved under the EU's decentralized procedure for bowel cleansing prior to any pr...